Speaker illustration

Professor Damien Gruson

Cliniques Saint-Luc UCL, Brussels (Belgium)

Member of:

European Society of Cardiology
Heart Failure Association

Professor Damien Gruson was awarded his degree of Pharmacist and later of Specialist in Laboratory Medicine from the Catholic University of Louvain, Brussels, Belgium. He is the head of the department of Clinical Biochemistry of the Cliniques Universitaires Saint Luc. He is also member of the research unit on Endocrinology Diabetes and Nutrition of the Catholic University of Louvain. Pr. D. Gruson has published numerous articles in several international peer-reviewed journals. Pr. D. Gruson is member of the division on Emerging Technology of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Pr. D. Gruson is also Fellow of the European Society of Cardiology.

Increase of CA125 in Heart Failure with reduced ejection fraction: association with cardiovascular mortality, Galectin-3 and Fibroblast Growth Factor-23

Event: Heart Failure 2022

Topic: Biomarkers

Session: Heart Failure ePosters - focus on Chronic Heart Failure 2

Thumbnail

The ratio of fibroblast growth factor 23 to phosphorus as a predictor of cardiovascular death in heart failure patients with reduced ejection fraction.

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail

Determinant factors of plasma fibroblast growth factor 23 levels in patients with heart failure patients with reduced ejection fraction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail

Increase of high molecular weight adiponectin in heart failure patients with reduced ejection fraction.

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail

Incremental value of intact fibroblast Growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patientsg

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail

Combining natriuretic peptides and 1, 25-dihydroxyvitamin D testing improves the predictive value for cardiovascular death in heart failure

Event: HEART FAILURE 2016

Topic: Natriuretic peptides

Session: Biomarkers

Thumbnail

Testing for soluble ST2 in heart failure patients: reliability of a point of care method

Event: HEART FAILURE 2016

Topic: Inflammation

Session: Biomarkers

Thumbnail

Soluble ST2 and vitamin D, a potent deleterious interaction for the heart

Event: HEART FAILURE 2016

Topic: Biomarkers, other

Session: Biomarkers

Thumbnail

This platform is supported by

logo Novo Nordisk